114 related articles for article (PubMed ID: 38618968)
1. Association of single-point insulin sensitivity estimator index (SPISE) with future cardiovascular outcomes in patients with type 2 diabetes.
Deng S; Hu X; Zhang X
Diabetes Obes Metab; 2024 Jul; 26(7):2820-2829. PubMed ID: 38618968
[TBL] [Abstract][Full Text] [Related]
2. Modification and Validation of the Triglyceride-to-HDL Cholesterol Ratio as a Surrogate of Insulin Sensitivity in White Juveniles and Adults without Diabetes Mellitus: The Single Point Insulin Sensitivity Estimator (SPISE).
Paulmichl K; Hatunic M; Højlund K; Jotic A; Krebs M; Mitrakou A; Porcellati F; Tura A; Bergsten P; Forslund A; Manell H; Widhalm K; Weghuber D; Anderwald CH; ;
Clin Chem; 2016 Sep; 62(9):1211-9. PubMed ID: 27471037
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT).
Robins SJ; Rubins HB; Faas FH; Schaefer EJ; Elam MB; Anderson JW; Collins D;
Diabetes Care; 2003 May; 26(5):1513-7. PubMed ID: 12716814
[TBL] [Abstract][Full Text] [Related]
4. SPISE and other fasting indexes of insulin resistance: risks of coronary heart disease or type 2 diabetes. Comparative cross-sectional and longitudinal aspects.
Cederholm J; Zethelius B
Ups J Med Sci; 2019 Nov; 124(4):265-272. PubMed ID: 31694444
[No Abstract] [Full Text] [Related]
5. Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease.
Furthner D; Anderwald CH; Bergsten P; Forslund A; Kullberg J; Ahlström H; Manell H; Ciba I; Mangge H; Maruszczak K; Koren P; Schütz S; Brunner SM; Schneider AM; Weghuber D; Mörwald K
Front Endocrinol (Lausanne); 2022; 13():830012. PubMed ID: 35185803
[TBL] [Abstract][Full Text] [Related]
6. Severity of Diabetic Retinopathy and the Risk of Future Cerebrovascular Disease, Cardiovascular Disease, and All-Cause Mortality.
Modjtahedi BS; Wu J; Luong TQ; Gandhi NK; Fong DS; Chen W
Ophthalmology; 2021 Aug; 128(8):1169-1179. PubMed ID: 33359888
[TBL] [Abstract][Full Text] [Related]
7. The single-point insulin sensitivity estimator (SPISE) index is a strong predictor of abnormal glucose metabolism in overweight/obese children: a long-term follow-up study.
Barchetta I; Dule S; Bertoccini L; Cimini FA; Sentinelli F; Bailetti D; Marini G; Barbonetti A; Loche S; Cossu E; Cavallo MG; Baroni MG
J Endocrinol Invest; 2022 Jan; 45(1):43-51. PubMed ID: 34142364
[TBL] [Abstract][Full Text] [Related]
8. Single Point Insulin Sensitivity Estimator (SPISE) As a Prognostic Marker for Emerging Dysglycemia in Children with Overweight or Obesity.
Stein R; Koutny F; Riedel J; Dörr N; Meyer K; Colombo M; Vogel M; Anderwald CH; Blüher M; Kiess W; Körner A; Weghuber D
Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677025
[TBL] [Abstract][Full Text] [Related]
9. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
[TBL] [Abstract][Full Text] [Related]
10. Walking decreased risk of cardiovascular disease mortality in older adults with diabetes.
Smith TC; Wingard DL; Smith B; Kritz-Silverstein D; Barrett-Connor E
J Clin Epidemiol; 2007 Mar; 60(3):309-17. PubMed ID: 17292026
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
[TBL] [Abstract][Full Text] [Related]
12. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study.
Lopez-Jaramillo P; Gomez-Arbelaez D; Martinez-Bello D; Abat MEM; Alhabib KF; Avezum Á; Barbarash O; Chifamba J; Diaz ML; Gulec S; Ismail N; Iqbal R; Kelishadi R; Khatib R; Lanas F; Levitt NS; Li Y; Mohan V; Mony PK; Poirier P; Rosengren A; Soman B; Wang C; Wang Y; Yeates K; Yusuf R; Yusufali A; Zatonska K; Rangarajan S; Yusuf S
Lancet Healthy Longev; 2023 Jan; 4(1):e23-e33. PubMed ID: 36521498
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction.
Zoppini G; Targher G; Negri C; Stoico V; Gemma ML; Bonora E
Atherosclerosis; 2010 Sep; 212(1):287-91. PubMed ID: 20510417
[TBL] [Abstract][Full Text] [Related]
14. Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.
Rådholm K; Chalmers J; Ohkuma T; Peters S; Poulter N; Hamet P; Harrap S; Woodward M
Diabetes Obes Metab; 2018 Aug; 20(8):1903-1910. PubMed ID: 29603537
[TBL] [Abstract][Full Text] [Related]
15. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
[TBL] [Abstract][Full Text] [Related]
16. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study.
Kaze AD; Santhanam P; Musani SK; Ahima R; Echouffo-Tcheugui JB
J Am Heart Assoc; 2021 Apr; 10(7):e016947. PubMed ID: 33728932
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Mortality and Major Cardiovascular Events Among Adults With Type 2 Diabetes Using Human vs Analogue Insulins.
Neugebauer R; Schroeder EB; Reynolds K; Schmittdiel JA; Loes L; Dyer W; Desai JR; Vazquez-Benitez G; Ho PM; Anderson JP; Pimentel N; O'Connor PJ
JAMA Netw Open; 2020 Jan; 3(1):e1918554. PubMed ID: 31977057
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men.
Kuusisto J; Lempiäinen P; Mykkänen L; Laakso M
Diabetes Care; 2001 Sep; 24(9):1629-33. PubMed ID: 11522711
[TBL] [Abstract][Full Text] [Related]
20. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.
Liao KP; Liu J; Lu B; Solomon DH; Kim SC
Arthritis Rheumatol; 2015 May; 67(8):2004-10. PubMed ID: 25917955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
